Kundu M - Search Results

1

Sala A, Kundu M, Casella I, Engelhard A, Calabretta B, Grasso L, Paggi MG, Giordano A, Watson RJ, Khalili K, Peschle C. Sala A, et al. Among authors: kundu m. Proc Natl Acad Sci U S A. 1997 Jan 21;94(2):532-6. doi: 10.1073/pnas.94.2.532. Proc Natl Acad Sci U S A. 1997. PMID: 9012818 Free PMC article.

2

Evidence that a cell cycle regulator, E2F1, down-regulates transcriptional activity of the human immunodeficiency virus type 1 promoter.

Kundu M, Srinivasan A, Pomerantz RJ, Khalili K. Kundu M, et al. J Virol. 1995 Nov;69(11):6940-6. doi: 10.1128/JVI.69.11.6940-6946.1995. J Virol. 1995. PMID: 7474112 Free PMC article.

3

TAR-independent activation of HIV-1 requires the activation domain but not the RNA-binding domain of Tat.

Taylor JP, Kundu M, Khalili K. Taylor JP, et al. Among authors: kundu m. Virology. 1993 Aug;195(2):780-5. doi: 10.1006/viro.1993.1430. Virology. 1993. PMID: 8337844

4

GA/GC-rich sequence confers Tat responsiveness to human neurotropic virus promoter, JCVL, in cells derived from central nervous system.

Chowdhury M, Kundu M, Khalili K. Chowdhury M, et al. Among authors: kundu m. Oncogene. 1993 Apr;8(4):887-92. Oncogene. 1993. PMID: 8384357

5

Association of Pur alpha and E2F-1 suppresses transcriptional activity of E2F-1.

Darbinian N, Gallia GL, Kundu M, Shcherbik N, Tretiakova A, Giordano A, Khalili K. Darbinian N, et al. Among authors: kundu m. Oncogene. 1999 Nov 4;18(46):6398-402. doi: 10.1038/sj.onc.1203011. Oncogene. 1999. PMID: 10597240

6

The transcription factor E2F-1 modulates TGF-beta1 RNA expression in glial cells.

Thatikunta P, Raj GV, Kundu M, Khalili K, Amini S. Thatikunta P, et al. Among authors: kundu m. Oncogene. 1997 Jun 19;14(24):2959-69. doi: 10.1038/sj.onc.1201129. Oncogene. 1997. PMID: 9205103

7

Interaction between cell cycle regulator, E2F-1, and NF-kappaB mediates repression of HIV-1 gene transcription.

Kundu M, Guermah M, Roeder RG, Amini S, Khalili K. Kundu M, et al. J Biol Chem. 1997 Nov 21;272(47):29468-74. doi: 10.1074/jbc.272.47.29468. J Biol Chem. 1997. PMID: 9368006 Free article.

8

HIV-1 Tat elongates the G1 phase and indirectly promotes HIV-1 gene expression in cells of glial origin.

Kundu M, Sharma S, De Luca A, Giordano A, Rappaport J, Khalili K, Amini S. Kundu M, et al. J Biol Chem. 1998 Apr 3;273(14):8130-6. doi: 10.1074/jbc.273.14.8130. J Biol Chem. 1998. PMID: 9525916 Free article.

9

HIV-1 regulatory protein tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif.

Kundu M, Ansari SA, Chepenik LG, Pomerantz RJ, Khalili K, Rappaport J, Amini S. Kundu M, et al. J Hum Virol. 1999 Mar-Apr;2(2):72-80. J Hum Virol. 1999. PMID: 10225209

10

Potent obatoclax cytotoxicity and activation of triple death mode killing across infant acute lymphoblastic leukemia.

Urtishak KA, Edwards AY, Wang LS, Hudome A, Robinson BW, Barrett JS, Cao K, Cory L, Moore JS, Bantly AD, Yu QC, Chen IM, Atlas SR, Willman CL, Kundu M, Carroll AJ, Heerema NA, Devidas M, Hilden JM, Dreyer ZE, Hunger SP, Reaman GH, Felix CA. Urtishak KA, et al. Among authors: kundu m. Blood. 2013 Apr 4;121(14):2689-703. doi: 10.1182/blood-2012-04-425033. Epub 2013 Feb 7. Blood. 2013. PMID: 23393050 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

503 results

Search Page

Filters